We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 03, 2019

Outcomes With Canagliflozin According to Baseline BMI

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Clinical Outcomes With Canagliflozin According to Baseline Body Mass Index: Results From Post Hoc Analyses of the CANVAS Program
Diabetes Obes Metab 2019 Nov 14;[EPub Ahead of Print], T Ohkuma, L Van Gaal, W Shaw, KW Mahaffey, D de Zeeuw, DR Matthews, V Perkovic, B Neal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading